Agios Pharm Stock Price on July 21, 2025
| AGIO Stock | USD 37.41 0.46 1.21% |
If you're considering investing in Agios Stock, it is important to understand the factors that can impact its price. As of today, the current price of Agios Pharm stands at 37.41, as last reported on the 24th of September, with the highest price reaching 37.41 and the lowest price hitting 37.41 during the day. Agios Pharm appears to be very steady, given 3 months investment horizon. Agios Pharm secures Sharpe Ratio (or Efficiency) of 0.08, which signifies that the company had a 0.08 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Agios Pharm, which you can use to evaluate the volatility of the firm. Please makes use of Agios Pharm's Mean Deviation of 2.11, downside deviation of 3.2, and Risk Adjusted Performance of 0.0492 to double-check if our risk estimates are consistent with your expectations. At this time, Agios Pharm's Total Stockholder Equity is very stable compared to the past year. As of the 24th of September 2025, Liabilities And Stockholders Equity is likely to grow to about 1.7 B, while Common Stock Total Equity is likely to drop about 49.5 K. . As of the 24th of September 2025, Price Earnings Ratio is likely to grow to 2.91, while Price To Sales Ratio is likely to drop 32.84. Agios Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Price Book 1.6202 | Enterprise Value Ebitda (2.33) | Price Sales 54.2849 | Shares Float 51.4 M | Wall Street Target Price 46.6667 |
Related Headline
Crinetics Pharmaceuticals Headline on 21st of July 2025
Crinetics Pharmaceuticals Palsonify Gains Positive Endorseme... by news.google.com
Crinetics Pharmaceuticals Palsonify Gains Positive Endorsement for Acromegaly Treatment with Promising Pipeline Expansion TipRanks
Agios Pharm Valuation on July 21, 2025
It is possible to determine the worth of Agios Pharm on a given historical date. On July 21, 2025 Agios was worth 40.09 at the beginning of the trading date compared to the closed value of 39.92. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Agios Pharm stock. Still, in general, we apply an absolute valuation method to find Agios Pharm's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Agios Pharm where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Agios Pharm's related companies.
| Open | High | Low | Close | Volume | |
| 40.70 | 41.19 | 39.96 | 40.00 | 824,551 | |
07/21/2025 | 40.09 | 40.60 | 39.65 | 39.92 | 429,897 |
| 39.58 | 39.95 | 38.48 | 39.66 | 825,957 |
| Backtest Agios Pharm | | | Agios Pharm History | | | Agios Pharm Valuation | Previous | Next |
Agios Pharm Trading Date Momentum on July 21, 2025
| On July 22 2025 Agios Pharm was traded for 39.66 at the closing time. The top price for the day was 39.95 and the lowest listed price was 38.48 . The trading volume for the day was 826 K. The trading history from July 22, 2025 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.65% . The overall trading delta against the current closing price is 7.57% . |
Agios Pharm Fundamentals Correlations and Trends
By evaluating Agios Pharm's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Agios Pharm's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Agios financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Agios Pharm Stock history
Agios Pharm investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Agios is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Agios Pharm will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Agios Pharm stock prices may prove useful in developing a viable investing in Agios Pharm
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 57.9 M | 49.8 M | |
| Net Loss | -266.6 M | -253.2 M |
Agios Pharm Quarterly Net Working Capital |
|
Agios Pharm Stock Technical Analysis
Agios Pharm technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Agios Pharm Period Price Range
Low | September 24, 2025
| High |
0.00 | 0.00 |
Agios Pharm cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Agios Pharm September 24, 2025 Market Strength
Market strength indicators help investors to evaluate how Agios Pharm stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Agios Pharm shares will generate the highest return on investment. By undertsting and applying Agios Pharm stock market strength indicators, traders can identify Agios Pharm entry and exit signals to maximize returns
Agios Pharm Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Agios Pharm's price direction in advance. Along with the technical and fundamental analysis of Agios Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Agios to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0492 | |||
| Jensen Alpha | 0.0163 | |||
| Total Risk Alpha | (0.42) | |||
| Sortino Ratio | 0.0141 | |||
| Treynor Ratio | 0.1455 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agios Pharm. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. To learn how to invest in Agios Stock, please use our How to Invest in Agios Pharm guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agios Pharm. If investors know Agios will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agios Pharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 11.44 | Revenue Per Share | Quarterly Revenue Growth 0.446 | Return On Assets | Return On Equity |
The market value of Agios Pharm is measured differently than its book value, which is the value of Agios that is recorded on the company's balance sheet. Investors also form their own opinion of Agios Pharm's value that differs from its market value or its book value, called intrinsic value, which is Agios Pharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agios Pharm's market value can be influenced by many factors that don't directly affect Agios Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agios Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agios Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agios Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.